A detailed history of Donaldson Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Donaldson Capital Management, LLC holds 35,284 shares of PFE stock, worth $932,556. This represents 0.04% of its overall portfolio holdings.

Number of Shares
35,284
Previous 39,251 10.11%
Holding current value
$932,556
Previous $1.1 Million 7.01%
% of portfolio
0.04%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$27.7 - $31.39 $109,885 - $124,524
-3,967 Reduced 10.11%
35,284 $1.02 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $137,768 - $161,438
5,454 Added 16.14%
39,251 $1.1 Million
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $2,770 - $3,181
-107 Reduced 0.32%
33,797 $937,000
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $50,117 - $65,096
-1,918 Reduced 5.35%
33,904 $976,000
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $684,222 - $799,788
-21,322 Reduced 37.31%
35,822 $1.19 Million
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $3.31 Million - $3.83 Million
-91,732 Reduced 61.62%
57,144 $2.1 Million
Q1 2023

Apr 13, 2023

SELL
$39.39 - $51.28 $14.8 Million - $19.3 Million
-376,831 Reduced 71.68%
148,876 $6.07 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $188,877 - $246,558
4,524 Added 0.87%
525,707 $26.9 Million
Q3 2022

Oct 13, 2022

SELL
$43.76 - $53.42 $18.8 Million - $23 Million
-429,996 Reduced 45.21%
521,183 $22.8 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $817,299 - $969,061
17,565 Added 1.88%
951,179 $49.9 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $15.4 Million - $19.1 Million
-336,158 Reduced 26.47%
933,614 $48.3 Million
Q4 2021

Jan 21, 2022

BUY
$41.32 - $61.25 $1.08 Million - $1.6 Million
26,161 Added 2.1%
1,269,772 $75 Million
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $1.8 Million - $2.32 Million
45,923 Added 3.83%
1,243,611 $53.5 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $2.54 Million - $2.88 Million
70,773 Added 6.28%
1,197,688 $46.9 Million
Q1 2021

May 05, 2021

BUY
$33.49 - $37.77 $6.62 Million - $7.46 Million
197,615 Added 21.26%
1,126,915 $40.8 Million
Q4 2020

Jan 11, 2021

BUY
$33.47 - $42.56 $6,325 - $8,043
189 Added 0.02%
929,300 $34.2 Million
Q3 2020

Nov 02, 2020

SELL
$31.75 - $37.25 $53,467 - $62,729
-1,684 Reduced 0.18%
929,111 $32.4 Million
Q2 2020

Jul 27, 2020

BUY
$30.12 - $36.54 $1.58 Million - $1.91 Million
52,379 Added 5.96%
930,795 $30.4 Million
Q1 2020

Apr 16, 2020

BUY
$27.03 - $38.62 $910,748 - $1.3 Million
33,694 Added 3.99%
878,416 $28.7 Million
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $6.68 Million - $7.58 Million
202,829 Added 31.6%
844,722 $33.1 Million
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $19,331 - $25,067
-595 Reduced 0.09%
641,893 $23.1 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $91,081 - $102,263
2,463 Added 0.38%
642,488 $27.8 Million
Q1 2019

Apr 01, 2019

SELL
$37.5 - $41.2 $4.6 Million - $5.05 Million
-122,610 Reduced 16.08%
640,025 $27.2 Million
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $859,842 - $980,314
22,351 Added 3.02%
762,635 $33.3 Million
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $710,461 - $861,745
20,611 Added 2.86%
740,284 $32.6 Million
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $177,597 - $189,336
5,385 Added 0.75%
719,673 $26.1 Million
Q1 2018

Apr 30, 2018

BUY
$31.91 - $37.02 $299,666 - $347,654
9,391 Added 1.33%
714,288 $25.4 Million
Q4 2017

Jan 30, 2018

BUY
$33.26 - $35.29 $22.9 Million - $24.3 Million
689,036 Added 4344.22%
704,897 $25.5 Million
Q4 2017

Jan 26, 2018

SELL
$33.26 - $35.29 $22 Million - $23.3 Million
-660,345 Reduced 97.65%
15,861 $574,000
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $21 Million - $23.1 Million
676,206
676,206 $24.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Donaldson Capital Management, LLC Portfolio

Follow Donaldson Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donaldson Capital Management, LLC with notifications on news.